mAChR Inhibitors

mAChR1

mAChR2

mAChR3

mAChR4

mAChR5

mAChR Inhibitors, Agonists, Antagonists & Modulators

Product Name	mAChR1	mAChR2	mAChR3	mAChR4	mAChR5	Purity
Clozapine N-oxide			mAChR3	mAChR4		99.98%
Deschloroclozapine			mAChR3	mAChR4		99.83%
Pilocarpine Hydrochloride			mAChR3			99.98%
Atropine				mAChR4		99.87%
Clozapine N-oxide dihydrochloride			mAChR3	mAChR4		99.97%
ASP8302			mAChR3
PCS1055				mAChR4, IC₅₀: 18.1 nM mAChR4, Kd: 5.72 nM		98.02%
(Rac)-VU 6008667					mAChR5	99.85%
Clozapine	mAChR1, Ki: 9.5 nM (Antagonist)			mAChR4, EC₅₀: 11 nM (Agonist)		99.97%
Pilocarpine			mAChR3			99.82%
Xanomeline	mAChR1			mAChR4		99.52%
Methacholine chloride			mAChR3			≥98.0%
Atropine sulfate				mAChR4		99.74%
(S)-(+)-Dimethindene maleate	mAChR1, pKi: 7.08	mAChR2, pKi: 7.78	mAChR3, pKi: 6.70	mAChR4, pKi: 7.00		99.94%
DREADD agonist 21			mAChR3			98.95%
Atropine sulfate monohydrate				mAChR4		99.68%
Xanomeline tartrate	mAChR1			mAChR4		99.93%
Emraclidine				mAChR4		99.82%
Tropicamide				mAChR4		99.22%
Pirenzepine dihydrochloride	mAChR1					99.89%
4-DAMP			mAChR3		mAChR5	99.99%
Diphenidol hydrochloride	mAChR1	mAChR2	mAChR3	mAChR4		99.95%
Cevimeline hydrochloride hemihydrate	mAChR1		mAChR3			99.52%
Ipratropium bromide	mAChR1	mAChR2	mAChR3			99.82%
Dicyclomine hydrochloride	mAChR1	mAChR2				≥98.0%
Oxotremorine sesquifumarate		mAChR2				≥98.0%
N-Desmethylclozapine	mAChR1					98.99%
VU0357017 hydrochloride	mAChR1					99.91%
Umeclidinium bromide	mAChR1				mAChR5	99.72%
Smilagenin	mAChR1					≥98.0%
Batefenterol		mAChR2	mAChR3			98.30%
VU6019650					mAChR5, IC₅₀: 36 nM	98.61%
VU6028418				mAChR4		99.52%
Imidafenacin			mAChR3			99.32%
VU0152100				mAChR4		98.98%
Telenzepine dihydrochloride	mAChR1					99.08%
MK-6884				mAChR4		99.11%
McN-A-343	mAChR1					99.77%
Sofpironium bromide			mAChR3	mAChR4	mAChR5	98.26%
Aceclidine	mAChR1		mAChR3			99.23%
Ipratropium bromide hydrate	mAChR1, IC₅₀: 2.9 nM	mAChR2, IC₅₀: 2 nM	mAChR3, IC₅₀: 1.7 nM			99.82%
Talsaclidine		mAChR2	mAChR3			≥98.0%
TBPB	mAChR1					99.74%
VU0364572 TFA	mAChR1, EC₅₀: 0.11 μM					99.27%
ML375					mAChR5	99.70%
PD 102807				mAChR4		98.52%
VU 0365114					mAChR5	99.41%
Olanzapine-d₃	mAChR1					99.09%
Penehyclidine hydrochloride	mAChR1		mAChR3			99.2%
Clozapine (Standard)	mAChR1			mAChR4		99.98%
Atropine (Standard)				mAChR4		99.87%
(Rac)-5-Hydroxymethyl Tolterodine hydrochloride	mAChR1		mAChR3	mAChR4	mAChR5
Tarafenacin D-tartrate			mAChR3			99.86%
PDE4-IN-4			mAChR3
VLVNTFCDSCIPKTYWNLGY TFA			mAChR3
mAChR antagonist 1	mAChR1, Ki: 255 nM	mAChR2, Ki: >1000 nM	mAChR3, Ki: 121 nM	mAChR4, Ki: 158 nM	mAChR5, Ki: 255 nM	99.59%
Solifenacin hydrochloride	mAChR1	mAChR2	mAChR3			99.71%
Tarafenacin			mAChR3
YM-58790	mAChR1, Ki: 28 nM	mAChR2, Ki: 260 nM	mAChR3, Ki: 15 nM			98.21%
Penehyclidine	mAChR1		mAChR3
Dicyclomine	mAChR1	mAChR2
PF-3635659			mAChR3
rel-Biperiden EP impurity B-d₅	mAChR1
N-Desmethylclozapine-d₈	mAChR1
YM-58790 free base	mAChR1, Ki: 28 nM	mAChR2, Ki: 260 nM	mAChR3, Ki: 15 nM
HY-078020			mAChR3
(±)-Darifenacin-d₄ hydrobromide			mAChR3
Solifenacin-d₅ succinate	mAChR1	mAChR2	mAChR3
Lu 26-046	mAChR1, Ki: 0.51 nM	mAChR2, Ki: 26 nM	mAChR3, Ki: 5 nM
M1 ligand 1	mAChR1
Aceclidine hydrochloride	mAChR1		mAChR3			≥98.0%
J 104129 fumarate		mAChR2, Ki: 490 nM	mAChR3, Ki: 4.2 nM
Umeclidinium-d₁₀ bromide	mAChR1				mAChR5
Pilocarpine-d₃ hydrochloride			mAChR3
Diphenidol	mAChR1	mAChR2	mAChR3	mAChR4
5-Hydroxymethyl Tolterodine-d₁₄ formate	mAChR1		mAChR3	mAChR4	mAChR5
(±)-Darifenacin-d₄			mAChR3
VU6004256	mAChR1, EC₅₀: 155 nM
rel-Biperiden EP impurity A-d₅	mAChR1
PTAC oxalate	mAChR1, Ki: 0.6 nM	mAChR2, Ki: 2.8 nM	mAChR3, Ki: 0.2 nM	mAChR4, Ki: 0.2 nM	mAChR5, Ki: 0.8 nM
LAS190792	mAChR1, pIC₅₀: 8.9	mAChR2, pIC₅₀: 8.8	mAChR3, pIC₅₀: 8.8	mAChR4, pIC₅₀: 9.2	mAChR5, pIC₅₀: 8.2
Biperiden-d₅ hydrochloride	mAChR1
DIBA-Cy5	mAChR1, Kd: 104.5 nM	mAChR2, Kd: 1.80 nM
M1/M2/M4 muscarinic agonist 1	mAChR1, EC₅₀: 26 nM	mAChR2, EC₅₀: 210 nM		mAChR4, EC₅₀: 6.5 nM
CHF-6550			mAChR3, pKi: 9.3
Pirenzepine-d₈	mAChR1
rel-Biperiden-d₅	mAChR1
M1/M4 muscarinic agonist 1	mAChR1, EC₅₀: 55 nM			mAChR4, EC₅₀: 14 nM
VU0448088				mAChR4, EC₅₀: 56 nM
Solifenacin-d₇ hydrochloride	mAChR1	mAChR2	mAChR3
TAAR1 agonist 2		mAChR2, pEC₅₀: 5
Umeclidinium-d₅ bromide	mAChR1				mAChR5
M4 mAChR Modulator-1				mAChR4
Revatropate	mAChR1	mAChR2	mAChR3
Rispenzepine	mAChR1		mAChR3
MHP 133	mAChR1	mAChR2
(1R,3S-)Solifenacin-d₅ hydrochloride	mAChR1	mAChR2	mAChR3
Clozapine hydrochloride	mAChR1, Ki: 9.5 nM			mAChR4, EC₅₀: 11 nM

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4